Skip to main content

Table 3 Incremental cost of universal GA-I newborn screening per 100,000 neonates

From: Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis

  Mean value 95% CI
Incremental cost, 20 years horizon −30,682 € −14,550 € to −49,401 €
Incremental cost, 70 years horizon −36,743 € −19,072 € to −57,365 €